Form 8-K - Current report:
SEC Accession No. 0001520138-24-000400
Filing Date
2024-10-29
Accepted
2024-10-29 06:00:36
Documents
18
Period of Report
2024-10-28
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT bivi-20241029_8k.htm   iXBRL 8-K 35737
2 EXHIBIT 5.1 bivi-20241029_8kex5z1.htm EX-5.1 16211
3 EXHIBIT 10.1 bivi-20241029_8kex10z1.htm EX-10.1 398540
4 EXHIBIT 99.1 bivi-20241029_8kex99z1.htm EX-99.1 10489
8 GRAPHIC image_01.jpg GRAPHIC 22221
9 GRAPHIC image_02.jpg GRAPHIC 15630
  Complete submission text file 0001520138-24-000400.txt   797856

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE bivi-20241028.xsd EX-101.SCH 3027
6 XBRL LABEL FILE bivi-20241028_lab.xml EX-101.LAB 34240
7 XBRL PRESENTATION FILE bivi-20241028_pre.xml EX-101.PRE 24173
20 EXTRACTED XBRL INSTANCE DOCUMENT bivi-20241029_8k_htm.xml XML 3568
Mailing Address 680 W NYE LANE SUITE 201 CARSON CITY NV 89703
Business Address 680 W NYE LANE SUITE 201 CARSON CITY NV 89703 775-888-3162
BIOVIE INC. (Filer) CIK: 0001580149 (see all company filings)

EIN.: 462510769 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-39015 | Film No.: 241402437
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)